Cargando…

Inhibition Mechanism of Anti-TB Drug SQ109: Allosteric Inhibition of TMM Translocation of Mycobacterium Tuberculosis MmpL3 Transporter

[Image: see text] The mycolic acid transporter MmpL3 is driven by proton motive forces (PMF) and functions via an antiport mechanism. Although the crystal structures of the Mycobacterium smegmatis MmpL3 transporter alone and in complex with a trehalose monomycolate (TMM) substrate and an antitubercu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carbone, Justin, Paradis, Nicholas J., Bennet, Lucas, Alesiani, Mark C., Hausman, Katherine R., Wu, Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466384/ https://www.ncbi.nlm.nih.gov/pubmed/37589273 http://dx.doi.org/10.1021/acs.jcim.3c00616

Ejemplares similares

Study of SQ109 analogs binding to mycobacterium MmpL3 transporter using MD simulations and alchemical relative binding free energy calculations
por: Stampolaki, Marianna, et al.
Publicado: (2023)

MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature
por: Imran, Mohd., et al.
Publicado: (2022)

Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors
por: McNeil, Matthew B., et al.
Publicado: (2020)

Resistance against Membrane-Inserting MmpL3 Inhibitor through Upregulation of MmpL5 in Mycobacterium tuberculosis
por: Li, Ming, et al.
Publicado: (2020)

Molecular Mechanisms of MmpL3 Function and Inhibition
por: Williams, John T., et al.
Publicado: (2023)

Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis
por: Yamamoto, Kentaro, et al.
Publicado: (2021)

Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis
por: Grover, Shipra, et al.
Publicado: (2020)

Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
por: Li, Wei, et al.
Publicado: (2019)

In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites
por: Baek, Kyung-Hwa, et al.
Publicado: (2022)

The driving force for mycolic acid export by mycobacterial MmpL3 is proton translocation
por: Parish, Tanya
Publicado: (2022)

MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
por: Sethiya, Jigar P., et al.
Publicado: (2020)

Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
por: Degiacomi, Giulia, et al.
Publicado: (2017)

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor
por: Berube, Bryan, et al.
Publicado: (2023)

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor
por: Berube, Bryan, et al.
Publicado: (2023)

Mycobacterium tuberculosis senses host Interferon-γ via the membrane protein MmpL10
por: Ahmed, Mohamed, et al.
Publicado: (2022)

MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis
por: Melly, Geoff, et al.
Publicado: (2019)

Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors
por: Stevens, Casey M., et al.
Publicado: (2022)

Targeting MmpL3 for anti-tuberculosis drug development
por: Bolla, Jani R.
Publicado: (2020)

In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori
por: Makobongo, Morris O., et al.
Publicado: (2013)

Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450
por: Bukhdruker, Sergey, et al.
Publicado: (2020)

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth
por: Ray, Peter C., et al.
Publicado: (2021)

MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
por: Varela, Cristian, et al.
Publicado: (2012)

Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
por: Li, Wei, et al.
Publicado: (2017)

Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits
por: Egbelowo, Oluwaseun, et al.
Publicado: (2021)

Multi-epitope vaccine candidates based on mycobacterial membrane protein large (MmpL) proteins against Mycobacterium ulcerans
por: Ishwarlall, Tamara Z., et al.
Publicado: (2023)

MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines
por: Maslov, Dmitry A., et al.
Publicado: (2020)

Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
por: Wallis, Robert S., et al.
Publicado: (2012)

Use of Soluble Extracellular Regions of MmpL (SERoM) as Vaccines for Tuberculosis
por: Strong, Emily J., et al.
Publicado: (2018)

Structure-function analysis of MmpL7-mediated lipid transport in mycobacteria
por: Moolla, Nabiela, et al.
Publicado: (2021)

Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study
por: Shahbaaz, Mohd, et al.
Publicado: (2022)

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
por: Li, Wei, et al.
Publicado: (2018)

Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria
por: Fay, Allison, et al.
Publicado: (2019)

Cryo-EM structure of the trehalose monomycolate transporter, MmpL3, reconstituted into peptidiscs
por: Couston, Julie, et al.
Publicado: (2023)

Structures of the mycobacterial membrane protein MmpL3 reveal its mechanism of lipid transport
por: Su, Chih-Chia, et al.
Publicado: (2021)

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
por: Hanieh, Patrizia Nadia, et al.
Publicado: (2022)

Advances in Mechanisms Design : Proceedings of TMM 2012
por: Beran, Jaroslav, et al.
Publicado: (2012)

Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption
por: Shetty, Annanya, et al.
Publicado: (2018)

Cryo-EM structure and resistance landscape of M. tuberculosis MmpL3: An emergent therapeutic target
por: Adams, Oliver, et al.
Publicado: (2021)

Phospholipid homeostasis, membrane tenacity and survival of Mtb in lipid rich conditions is determined by MmpL11 function
por: Bothra, Ankur, et al.
Publicado: (2018)

A Hydrazine–Hydrazone Adamantine Compound Shows Antimycobacterial Activity and Is a Probable Inhibitor of MmpL3
por: Briffotaux, Julien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iuio64tj1005cqdp8vjeihmckc